Presentations by Chanel M. Ghesquiere

• Sat-25 from 16:00 - 17:30 in room Regency
  Poster Session — 2
  Differential pre-clinical efficacy of dual CDK4/6 and MEK inhibition in low-grade serous ovarian carcinoma based on KRAS/NF1 tumor mutational status